Quell

Also: Dictum Health's Lebanese pilot; New data on NeuroMetrix's Quell.

Also: Cricket Health raises $24 million, and NeuroMetrix releases Quell 2.0.

Earnings reports shared by neurostimulation and digital medicine company NeuroMetrix during a Q2 investors’ call showed a slight drop in total revenue as the company is preparing to place its marketing weight behind the launch of its updated wearable pain relief product, Quell.

In addition to the many device launches, several digital health companies use CES (formerly known as the Consumer Electronic Show) in Las Vegas as an opportunity to announce updates and major partnerships and collaborations.

Neurometrix has received FDA clearance for a new smartphone-controlled version of Quell, its wearable for pain relief, the company announced last week.

By: The MobiHealthNews Team By the end of CES15 MobiHealthNews has tracked more than 40 health device makers who either unveiled or launched products, announced updated pricing or new features for already known ones.